Patent 9650412 was granted and assigned to Genzyme on May, 2017 by the United States Patent and Trademark Office.
Provided herein are integrated continuous biomanufacturing processes for producing a therapeutic protein drug substance. Also provided are systems that are capable of continuously producing a therapeutic protein drug substance.